Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB26FT1T9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,720
Award facts
- Contract value 100% obligated
- $9,720.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $9,720.34 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The delivery order, issued on October 23, 2025, with an ultimate completion date of November 14, 2025, was awarded without a set-aside designation, indicating the vendor competed in an unrestricted procurement. DMS Pharmaceutical Group was selected based on its established performance as a critical supplier within the federal pharmaceutical supply chain, particularly for Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring medical supply needs for military healthcare facilities worldwide. The underlying indefinite delivery contract, designated SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. DMS Pharmaceutical Group's comprehensive product portfolio and demonstrated federal contracting capability position the company to fulfill diverse and specialized pharmaceutical requirements across the military medical system.
Quick answers
Who was awarded contract SPE2DB26FT1T9?
SPE2DB26FT1T9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DB26FT1T9 worth?
The government has obligated $9,720 on SPE2DB26FT1T9.
Is contract SPE2DB26FT1T9 an order under another contract?
Yes. SPE2DB26FT1T9 is a delivery order under SPE2DB20D9371, an indefinite delivery contract.
Was contract SPE2DB26FT1T9 competed?
The extent of competition for SPE2DB26FT1T9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award